Frequent Loss-of-Heterozygosity in CRISPR-Cas9-edited Early Human Embryos Endangered Species Previous and current positions include

Previous and current positions include

Clinical Epigenetics 11(1): 21

Professor Matthew W

KPIs and Benchmarking

Frequent Loss-of-Heterozygosity in CRISPR-Cas9-edited Early Human Embryos Endangered Species Previous and current positions includeFrequent Loss of Heterozygosity in CRISPR Cas9 edited Early Human Embryos DR. GREGORIO ALANIS LOBATO Gregorio obtained a BEng degree in Computer Systems Engineering at the National Polytechnic Institute in Mexico before moving to KAUST in Saudia Arabia to pursue MSc and PhD degrees in Computer Science and Computational Biology, respectively. Then, he became a postdoctoral fellow at the IMB in Mainz, Germany, where he developed methods to study the